• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number A35SX060040080
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Claudication (2550)
Event Date 01/23/2019
Event Type  Injury  
Manufacturer Narrative
The patient's weight is unknown.This information was not available from the facility.The patient required amputation on the treated limb.This is being reported as a follow-up to the clinical registry.Patient information regarding relevant tests or laboratory data is unknown.This information was not available from the facility.Report source: foreign- (b)(6) / study name: (b)(6) patient id (b)(6).Pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical registry.During the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was required.Per the ifu, pain (claudication) and amputation are listed as potential complications/adverse events.
 
Event Description
It was reported through a clinical registry that during the index procedure on (b)(6) 2018, a stellarex balloon catheter was used to treat the target lesion of the left proximal sfa in a claudicant patient.Approximately 8 months post index procedure, the patient underwent an amputation of the target limb (no further details are available) on (b)(6)2019.Per clinical evaluation, the amputation is not related to the study device or the procedure.
 
Manufacturer Narrative
Block b5: included initial amputation that occurred on (b)(6) 2018 and provided cause of amputation for the event on (b)(6) 2019.H3 other text : placeholder.
 
Event Description
Approximately 5 months post index procedure, the patient underwent a transtibial amputation of the target limb due to gangrene on (b)(6) 2018.Then approximately 3 months later, the patient experienced constant pain on the non-healing amputation site and underwent a transfemoral amputation of the target limb on (b)(6) 2019.Per clinical evaluation, the amputations are not related to the study device or the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
MDR Report Key9485154
MDR Text Key176234591
Report Number3009784280-2019-00730
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Type of Report Initial,Followup
Report Date 01/01/2005,11/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/27/2019
Device Model NumberA35SX060040080
Device Catalogue NumberA35SX060040080
Device Lot NumberFBZ17D10A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 11/25/2019
Initial Date FDA Received12/17/2019
Supplement Dates Manufacturer Received01/30/2020
Supplement Dates FDA Received02/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
-
-